BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15302953)

  • 21. Dynamics of Simian immunodeficiency virus-specific cytotoxic T-cell responses in tissues.
    Veazey RS; Lifson JD; Schmitz JE; Kuroda MJ; Piatak M; Pandrea I; Purcell J; Bohm R; Blanchard J; Williams KC; Lackner AA
    J Med Primatol; 2003 Aug; 32(4-5):194-200. PubMed ID: 14498979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses.
    Couillin I; Letourneur F; Lefèbvre P; Guillet JG; Martinon F
    Virology; 2001 Jan; 279(1):136-45. PubMed ID: 11145897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.
    Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
    Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of cytotoxic-T-lymphocyte memory induction without virus-specific CD4+ T-Cell help on control of a simian immunodeficiency virus challenge in rhesus macaques.
    Tsukamoto T; Takeda A; Yamamoto T; Yamamoto H; Kawada M; Matano T
    J Virol; 2009 Sep; 83(18):9339-46. PubMed ID: 19587045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: efficacy and evolution of cytotoxic T lymphocyte escape in macaques.
    Reece JC; Alcantara S; Gooneratne S; Jegaskanda S; Amaresena T; Fernandez CS; Laurie K; Hurt A; O'Connor SL; Harris M; Petravic J; Martyushev A; Grimm A; Davenport MP; Stambas J; De Rose R; Kent SJ
    J Virol; 2013 Apr; 87(8):4146-60. PubMed ID: 23345519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques.
    Hu X; Lu Z; Valentin A; Rosati M; Broderick KE; Sardesai NY; Marx PA; Mullins JI; Pavlakis GN; Felber BK
    Hum Vaccin Immunother; 2018; 14(9):2163-2177. PubMed ID: 29939820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virus replication and evolution drive the kinetics and specificity of SIV-specific cytotoxic T lymphocytes.
    Geretti AM; Osterhaus AD
    Immunol Rev; 2001 Oct; 183():109-14. PubMed ID: 11782251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation.
    Kobayashi M; Igarashi H; Takeda A; Kato M; Matano T
    J Virol; 2005 Sep; 79(17):11529-32. PubMed ID: 16103206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.
    Enose Y; Kita M; Yamamoto T; Suzuki H; Miyake A; Horiuchi R; Ibuki K; Kaneyasu K; Kuwata T; Takahashi E; Sakai K; Shinohara K; Miura T; Hayami M
    Arch Virol; 2004 Sep; 149(9):1705-20. PubMed ID: 15593414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo resistance to simian immunodeficiency virus superinfection depends on attenuated virus dose.
    Cranage MP; Sharpe SA; Whatmore AM; Polyanskaya N; Norley S; Cook N; Leech S; Dennis MJ; Hall GA
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1935-44. PubMed ID: 9714241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
    Nixon DF; Donahoe SM; Kakimoto WM; Samuel RV; Metzner KJ; Gettie A; Hanke T; Marx PA; Connor RI
    Virology; 2000 Jan; 266(1):203-10. PubMed ID: 10612675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abrogation of AIDS vaccine-induced cytotoxic T-lymphocyte efficacy in vivo due to a change in viral epitope flanking sequences.
    Moriya C; Igarashi H; Takeda A; Tsukamoto T; Kawada M; Yamamoto H; Inoue M; Iida A; Shu T; Hasegawa M; Nagai Y; Matano T
    Microbes Infect; 2008 Mar; 10(3):285-92. PubMed ID: 18316225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa.
    Cranage MP; Whatmore AM; Sharpe SA; Cook N; Polyanskaya N; Leech S; Smith JD; Rud EW; Dennis MJ; Hall GA
    Virology; 1997 Mar; 229(1):143-54. PubMed ID: 9123856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts.
    Friedrich TC; McDermott AB; Reynolds MR; Piaskowski S; Fuenger S; De Souza IP; Rudersdorf R; Cullen C; Yant LJ; Vojnov L; Stephany J; Martin S; O'Connor DH; Wilson N; Watkins DI
    J Virol; 2004 Sep; 78(18):10064-73. PubMed ID: 15331739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239.
    Evans DT; Bricker JE; Sanford HB; Lang S; Carville A; Richardson BA; Piatak M; Lifson JD; Mansfield KG; Desrosiers RC
    J Virol; 2005 Jun; 79(12):7707-20. PubMed ID: 15919923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag.
    Chen ZW; Shen L; Miller MD; Ghim SH; Hughes AL; Letvin NL
    J Immunol; 1992 Dec; 149(12):4060-6. PubMed ID: 1460291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.
    Dittmer U; Nisslein T; Bodemer W; Petry H; Sauermann U; Stahl-Hennig C; Hunsmann G
    Virology; 1995 Oct; 212(2):392-7. PubMed ID: 7571408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of multiple simian immunodeficiency virus (SIV)-specific CTL epitopes in sooty mangabeys with natural and experimentally acquired SIV infection.
    Kaur A; Yang J; Hempel D; Gritz L; Mazzara GP; McClure H; Johnson RP
    J Immunol; 2000 Jan; 164(2):934-43. PubMed ID: 10623842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
    Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS
    Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.